SMTL ID : 6b33.2 (1 other biounit)

Structure of RORgt in complex with a novel inverse agonist 3

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.48 Å

Oligo State

monomer

Ligands

1 x CF7: (2R)-N~2~-(3-chloro-4-cyanophenyl)-N~4~-[3-(cyclopropylmethyl)-2,4-dioxo-1-(propan-2-yl)-1,2,3,4-tetrahydroquinazolin-6-yl]morpholine-2,4-dicarboxamide(Non-covalent)

CF7.1: 15 residues within 4Å: Chain A: Q.22, C.56, H.59, L.60, M.94, V.97, M.101, A.104, V.112, F.113, F.114, F.124, I.136, F.137, H.215 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:H.59, A:L.60, A:V.97, A:V.112, A:F.124, A:F.137 Hydrogen bonds: A:F.113

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Sato, A. et al., Design and Synthesis of Conformationally Constrained ROR gamma t Inverse Agonists. Chemmedchem (2019)

Release Date

2018-11-21

Peptides

Nuclear receptor ROR-gamma: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Nuclear receptor ROR-gamma

Related Entries With Identical Sequence